Sign in

CIK 0001178670 · Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
770602661
Phone
(617) 551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
Open-market buys, last 90 days
$543,126
in 2 filings
Open-market sales, last 90 days
$398,855
in 1 filing

Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-03-03 Tanguler Tolga EVP, Chief Commercial Officer Sale −29 $246.18 $7K 28,014
2025-03-03 Tanguler Tolga EVP, Chief Commercial Officer Sale −3 $247.35 $742 28,011
2025-03-03 Tanguler Tolga EVP, Chief Commercial Officer Grant or award · Stock Option (right to buy) +7,819 7,819
2025-03-03 Garg Pushkal CMO & EVP Dev & Med Affairs Grant or award 10b5-1 +14,137 27,099
2025-03-03 Garg Pushkal CMO & EVP Dev & Med Affairs Sale 10b5-1 −213 $242.37 $52K 26,886
2025-03-03 Garg Pushkal CMO & EVP Dev & Med Affairs Sale 10b5-1 −235 $243.36 $57K 26,651
2025-03-03 Garg Pushkal CMO & EVP Dev & Med Affairs Sale 10b5-1 −158 $244.41 $39K 26,493
2025-03-03 Garg Pushkal CMO & EVP Dev & Med Affairs Sale 10b5-1 −116 $245.26 $28K 26,377
2025-03-03 Garg Pushkal CMO & EVP Dev & Med Affairs Sale 10b5-1 −48 $246.18 $12K 26,329
2025-03-03 Garg Pushkal CMO & EVP Dev & Med Affairs Sale 10b5-1 −5 $247.35 $1K 26,324
2025-03-03 Garg Pushkal CMO & EVP Dev & Med Affairs Sale 10b5-1 −1 $248.36 $248 26,323
2025-03-03 Garg Pushkal CMO & EVP Dev & Med Affairs Sale 10b5-1 −583 $243.13 $142K 25,740
2025-03-03 Garg Pushkal CMO & EVP Dev & Med Affairs Sale 10b5-1 −273 $244.43 $67K 25,467
2025-03-03 Garg Pushkal CMO & EVP Dev & Med Affairs Sale 10b5-1 −117 $245.53 $29K 25,350
2025-03-03 Garg Pushkal CMO & EVP Dev & Med Affairs Grant or award · Stock Option (right to buy) 10b5-1 +7,819 7,819
2025-03-03 Poulton Jeffrey V. EVP, Chief Financial Officer Grant or award +15,117 49,015
2025-03-03 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −350 $242.37 $85K 48,665
2025-03-03 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −382 $243.36 $93K 48,283
2025-03-03 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −258 $244.41 $63K 48,025
2025-03-03 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −189 $245.26 $46K 47,836

Page 32 of 41 · 816 trades